Treatment landscape of triple-negative breast cancer—expanded options, evolving needs

G Bianchini, C De Angelis, L Licata… - Nature reviews Clinical …, 2022 - nature.com
Tumour heterogeneity and a long-standing paucity of effective therapies other than
chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype …

Targeting PI3K/Akt signal transduction for cancer therapy

Y He, MM Sun, GG Zhang, J Yang, KS Chen… - Signal transduction and …, 2021 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …

Capivasertib in hormone receptor–positive advanced breast cancer

NC Turner, M Oliveira, SJ Howell… - … England Journal of …, 2023 - Mass Medical Soc
Background AKT pathway activation is implicated in endocrine-therapy resistance. Data on
the efficacy and safety of the AKT inhibitor capivasertib, as an addition to fulvestrant therapy …

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast …

SJ Howell, A Casbard, M Carucci, K Ingarfield… - The Lancet …, 2022 - thelancet.com
Background Capivasertib, an AKT inhibitor, added to fulvestrant, was previously reported to
improve progression-free survival in women with aromatase inhibitor-resistant oestrogen …

Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis

V Padmanaban, I Keller, ES Seltzer, BN Ostendorf… - Nature, 2024 - nature.com
Tumour innervation is associated with worse patient outcomes in multiple cancers,, which
suggests that it may regulate metastasis. Here we observed that highly metastatic mouse …

AKT as a therapeutic target for cancer

M Song, AM Bode, Z Dong, MH Lee - Cancer research, 2019 - AACR
Many cellular processes in cancer are attributed to kinase signaling networks. V-akt murine
thymoma viral oncogene homolog (AKT) plays a major role in the PI3K/AKT signaling …

Therapeutic strategies targeting FOXO transcription factors

G Calissi, EWF Lam, W Link - Nature reviews Drug discovery, 2021 - nature.com
FOXO proteins are transcription factors that are involved in numerous physiological
processes and in various pathological conditions, including cardiovascular disease, cancer …

The relation between PI3K/AKT signalling pathway and cancer

S Noorolyai, N Shajari, E Baghbani, S Sadreddini… - Gene, 2019 - Elsevier
Abstract Phosphatidylinositol 3-kinases (PI3Ks) are crucial coordinators of intracellular
signalling in response to the extracellular stimulators. Hyperactivation of PI3K signalling …

OncoKB: a precision oncology knowledge base

D Chakravarty, J Gao, S Phillips, R Kundra… - JCO precision …, 2017 - ascopubs.org
Purpose With prospective clinical sequencing of tumors emerging as a mainstay in cancer
care, an urgent need exists for a clinical support tool that distills the clinical implications …

AKT/PKB signaling: navigating the network

BD Manning, A Toker - Cell, 2017 - cell.com
The Ser and Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25
years ago and has been the focus of tens of thousands of studies in diverse fields of biology …